VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Linda Kaplan who wrote (3381)	12/11/1997 9:00:00 AM
From: blankmind	Read Replies (1) of 23519

-- Great product but lousy production has 3 cures: 1. Contract out production - to either a generic drug maker with x/s capacity - or to a "Merck-type" or 2. Hire on a project manager with a track record who can get the Lakewood, NJ plant up and running or 3. Sell the company to J&J or Merck - heck, with the product revenues and stellar balance sheet - $40 a share would be a nice point to start a bidding war Out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next